![Larry Altstiel](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: - $ in data 31/05/2026
Larry Douglas Altstiel was the founder of Provectra Therapeutics, Inc., founded in 2013, where the title held was Chief Executive Officer from 2013 to 2015.
Current jobs include Chief Medical Officer at Pinteon Therapeutics, Inc. and Chief Medical Officer at ProMIS Neurosciences, Inc. since 2022.
Former jobs include Director at Neurotrope, Inc. from 2014 to 2016; Vice President-Neuroscience Clinical Development at Pfizer Inc. in 2013; Vice President-Research Operations at Eisai Medical Research, Inc.; Senior VP & Head-Global Clinical Development at UCB Biosciences, Inc.; Vice President-Research Operations at Schering Plough, Inc.; and Chief Medical Officer & Executive Vice President at vTv Therapeutics, Inc. from 2015 to 2018.
Education includes undergraduate studies at the University of Illinois, a doctorate from The Rockefeller University, and a doctorate from The University of Miami Leonard M.
Miller School of Medicine.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 22/09/2025 | 0 ( -.--% ) | - $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| PROMIS NEUROSCIENCES, INC. | Direttore Tecnico/Scientifico/R&S | 19/04/2022 |
Pinteon Therapeutics, Inc.
 Pinteon Therapeutics, Inc. BiotechnologyHealth Technology Discovers and develops therapeutics for cancer treatment | Direttore Tecnico/Scientifico/R&S | - |
| Società | Posizione | Fine |
|---|---|---|
| VTV THERAPEUTICS INC. | Direttore Tecnico/Scientifico/R&S | 30/04/2018 |
| NEUROTROPE, INC. | Direttore/Membro del Consiglio | 11/02/2016 |
Provectra Therapeutics, Inc.
 Provectra Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Amministratore Delegato | 01/12/2015 |
| PFIZER INC. | Corporate Officer/Principal | 01/01/2013 |
Schering Plough, Inc. | Corporate Officer/Principal | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 12 |
|---|---|
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Neurotrope, Inc.
 Neurotrope, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for neurodegenerative diseases | Health Technology |
Pinteon Therapeutics, Inc.
Pinteon Therapeutics, Inc. BiotechnologyHealth Technology Discovers and develops therapeutics for cancer treatment | Health Technology |
ProMIS Neurosciences, Inc.
 ProMIS Neurosciences, Inc. BiotechnologyHealth Technology Discovers and develops precision medicine solutions for the treatment of neurodegenerative & misfolded protein diseases | Health Technology |
University of Illinois
 University of Illinois Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Rockefeller University
 The Rockefeller University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Eisai Medical Research, Inc. | |
UCB BioSciences, Inc. | Electronic Technology |
Schering Plough, Inc. | |
The University of Miami Leonard M. Miller School of Medicine
 The University of Miami Leonard M. Miller School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Provectra Therapeutics, Inc.
Provectra Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
vTv Therapeutics, Inc.
 vTv Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage pharmaceutical company which engages in discovery and development of orally administered small molecule drugs for treating metabolic and inflammatory disorders | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
